Tharimmune Launches New Website as Discussions with FDA Continue for Phase 2 Clinical Trial with TH104
The Company's early-stage immunology pipeline includes novel multi-specific antibodies targeting unique epitopes with novel mechanism...
Digital Journal
2 days ago